Immunocytochemical localization of monoamine oxidases A and B in human peripheral tissues and brain

被引:133
作者
Thorpe, Larry W. [1 ]
Westujnd, Karin N. [2 ]
Kochersperger, Lynn M. [1 ]
Abell, C. W. [1 ]
Denney, Richard M. [1 ]
机构
[1] Univ Texas Med Branch, Dept Human Biol Chem & Genet, Galveston, TX 77550 USA
[2] Univ Texas Med Branch, Dept Anat & Neurosci, Galveston, TX 77550 USA
关键词
monoamine oxidase A; monoamine oxidase B; human; brain; liver; lymphocyte; platelet; placenta; mitochondria; monoclonal antibody; immunocytochemistry;
D O I
10.1177/35.1.3025289
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Monoamine oxidases (MAO; EC 1.4.3.4.) A and B occur in the outer mitochondrial membrane and oxidize a number of important biogenic and xenobiotic amines. Monoclonal antibodies specific for human MAO A or B and immunocytochemical techniques were used to visualize the respective enzymes in human placenta, platelets, lymphocytes, liver, brain, and a human hepatoma cell line. MAO A was observed in the syncytiotrophoblast layer of term placenta, liver, and a subset of neurons in brain, but was not observed in platelets or lymphocytes, which are known to lack type A enzyme. MAO B was observed in platelets, lymphocytes, and liver, but not in placenta, which contains little or no MAO B. MAO B was also observed in a subset of neurons in the brain that was distinct from that which contained MAO A. MAO A and MAO B were also observed in some glia. Unlike most tissues examined, liver cells appeared to contain both forms of the enzyme. These studies show that MAO A and MAO B can be specifically visualized by immunocytochemical means in a variety of human cells and tissues and can provide a graphic demonstration of the high degree of cell specificity of expression of the two forms of the enzyme.
引用
收藏
页码:23 / 32
页数:10
相关论文
共 51 条
[1]  
ASK AL, 1982, ACTA PHARMACOL TOX, V51, P395
[2]  
ASK AL, 1984, MONOAMINE OXIDASE DI, P127
[3]   PROPERTIES OF MONOAMINE-OXIDASE (MAO) IN HUMAN-BLOOD PLATELETS, PLASMA, LYMPHOCYTES AND GRANULOCYTES [J].
BOND, PA ;
CUNDALL, RL .
CLINICA CHIMICA ACTA, 1977, 80 (02) :317-326
[4]  
BOYEM A, 1968, SCAN J CLIN LAB S97, V21, P31
[5]   MOLECULAR-WEIGHT DIFFERENCES BETWEEN HUMAN-PLATELET AND PLACENTAL MONOAMINE-OXIDASE [J].
BROWN, GK ;
POWELL, JF ;
CRAIG, IW .
BIOCHEMICAL PHARMACOLOGY, 1980, 29 (19) :2595-2603
[6]   IMMUNOLOGICAL STUDIES OF HUMAN MONOAMINE OXIDASES [J].
BROWN, GK ;
POWELL, JF ;
CRAIG, IW .
JOURNAL OF NEUROCHEMISTRY, 1982, 39 (05) :1266-1270
[7]   A PRIMATE MODEL OF PARKINSONISM - SELECTIVE DESTRUCTION OF DOPAMINERGIC-NEURONS IN THE PARS COMPACTA OF THE SUBSTANTIA NIGRA BY N-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE [J].
BURNS, RS ;
CHIUEH, CC ;
MARKEY, SP ;
EBERT, MH ;
JACOBOWITZ, DM ;
KOPIN, IJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (14) :4546-4550
[8]  
Callingham B. A., 1979, MONOAMINE OXIDASE ST, P81
[9]   DIFFERENCES IN A-FORM AND B-FORM OF MONO-AMINE OXIDASE REVEALED BY LIMITED PROTEOLYSIS AND PEPTIDE-MAPPING [J].
CAWTHON, RM ;
BREAKEFIELD, XO .
NATURE, 1979, 281 (5733) :692-694
[10]   DIFFERENCES IN THE STRUCTURE OF A AND B-FORMS OF HUMAN MONOAMINE-OXIDASE [J].
CAWTHON, RM ;
PINTAR, JE ;
HASELTINE, FP ;
BREAKEFIELD, XO .
JOURNAL OF NEUROCHEMISTRY, 1981, 37 (02) :363-372